Additionally, loss of the FLT3-wild-type allele and resultant copy number-neutral ITD homozygosity has been demonstrated in AML, particularly at disease progression, and is associated with a worse prognosis (49–51). Here, FLT3 is linked to acute myeloid leukemia.